June 30, 2015

The MedTech Strategist

The Specialty Drug Price Debate: Should Medtech be worried?

By David Cassak

As prices for specialty drugs like oncologics soar, outrage is mounting over the cost of the new therapies, prompting a debate about their value.  Could any of this spill over to medical devices?

read full article >